When it comes to point-of-care glucose testing, relying on at-home strip meters isn't enough. For lab-quality accuracy and reliable results, the CLIA-waived HemoCue® Glucose 201 System is the professional solution you need. Designed for healthcare providers, this analyzer delivers precise readings from a simple fingerstick test, making it ideal for managing patients with diabetes and identifying those at risk. Unlike traditional glucose strip meters, the HemoCue® Glucose 201 System offers the accuracy needed to support clinical decisions, including Oral Glucose Tolerance Tests (OGTT). With this system, you can confidently diagnose and treat diabetic patients, ensuring the highest standard of care in your practice.
Order Now HemoCue® Glucose 201 System Brochure
Order Now
The HemoCue® Glucose 201 System is specifically designed to measure blood glucose levels with precision and accuracy, making it an essential tool for various clinical applications:
The system provides critical data for diagnosing diabetes, allowing healthcare professionals to monitor and manage glucose levels in patients with diabetes effectively.
The analyzer helps identify individuals at risk for diabetes by detecting elevated blood glucose levels, enabling early intervention and prevention strategies.
The HemoCue® Glucose 201 System is CLIA-waived for conducting Oral Glucose Tolerance Tests (OGTT) in-office, a key diagnostic tool for assessing how a patient’s body processes glucose.
In addition to its use in diabetes care, the system is valuable for monitoring glucose levels in patients as part of routine health checks or when there are concerns about blood sugar levels due to other medical conditions.
The HemoCue® Glucose 201 System is designed with simplicity in mind, allowing healthcare professionals to obtain precise glucose measurements quickly and efficiently. Here’s how it works:
Begin by taking a small blood sample using a fingerstick. The system’s microcuvettes are designed to draw the correct amount of blood automatically, ensuring accurate results every time.
Once the blood sample is collected, insert the microcuvette into the HemoCue® Glucose 201 analyzer. The analyzer reads the sample and begins processing the data immediately.
In just a few moments, the analyzer provides lab-quality glucose results that you can rely on to make informed clinical decisions. The process is quick, easy, and minimizes the time patients spend waiting.
The HemoCue® Glucose 201 System is designed to meet the demanding needs of healthcare professionals, offering a range of benefits and features that enhance its usability and reliability in clinical settings:
The system delivers precise, lab-quality glucose readings directly at the point-of-care, ensuring that healthcare providers can make informed decisions with confidence.
With an intuitive three-step process—collecting the sample, inserting the microcuvette, and reading the results—the HemoCue® Glucose 201 System streamlines glucose testing, saving time and increasing workflow efficiency.
As a CLIA-waived device, this system is approved for in-office use, making it easier for healthcare providers to perform accurate glucose testing without the need for external lab services.
The HemoCue® Glucose 201 System is not just limited to routine glucose monitoring; it also supports Oral Glucose Tolerance Tests (OGTT), offering versatility for comprehensive diabetes screening and management.
The analyzer is designed to be compact and portable, allowing it to be easily integrated into various clinical environments, from small practices to larger healthcare facilities.
Built for professional use, the HemoCue® Glucose 201 System is known for its reliability and durability, ensuring consistent performance over time, even in high-demand settings.
The system complies with Clinical Laboratory Improvement Amendments (CLIA) regulations and is recognized for use with multiple CPT codes by the American Medical Association (AMA), helping practices remain compliant while facilitating reimbursement.
By providing fast and accurate glucose readings, the system enables timely interventions, which can significantly improve patient outcomes and enhance the overall quality of care.
Principle
Modified glucose dehydrogenase in which the total amount of glucose is measured at the end point photometrically
Calibration
Factory calibrated and traceable to ID GC-MS method, needs no further calibration and no coding
Testing
Sample Material
Capillary, venous or arterial whole blood including neonatal blood
Sample Volume
Approximately 5 μL whole blood
Measuring Time
40-240 seconds
Displayed Range
Plasma equivalent values 0-444 mg/dL
Device
Dimensions
6.3x1.69x3.35 in (160x43x85 mm)
Weight
0.77 lbs. (350 g), with batteries installed
Temp Ranges
Analyzer Storage
32-122 °F (0-50 °C)
Microcuvette Storage
Below 46 °F (8 °C), incl. freezer.
Up to 3 days in room temperature.
Analyzer Operation
64-86 °F (18-30 °C)
Quality Control
Built-in self-test; system can be verified using liquid control
Power
Cable
AC Adapter
Standard Batteries
4 AA batteries 1.5 V Alkaline
Rechargable Batteries
4 AA batteries 1.2 V NiMH
Interface
Connectable to HemoCue® DMU Docking Station
CPT Codes
82947-QW 82950-QW 82951-QW 82952-QW
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
Sources: https://www.hemocue.us/glucose201/